Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization
- 1 December 2009
- journal article
- Published by Elsevier BV in Computers & Chemical Engineering
- Vol. 33 (12), 2042-2054
- https://doi.org/10.1016/j.compchemeng.2009.06.005
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Population Pharmacokinetic-Pharmacodynamic Model for Neutropenia with Patient Subgroup Identification: Comparison across Anticancer DrugsClinical Cancer Research, 2006
- A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapyCancer Chemotherapy and Pharmacology, 2005
- Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002New England Journal of Medicine, 2005
- Measuring the side effects of taxane therapy in oncologyCancer, 2003
- Optimal Bang-Bang Controls for a Two-Compartment Model in Cancer ChemotherapyJournal of Optimization Theory and Applications, 2002
- Analysis of a mathematical model for the growth of tumors under the action of external inhibitorsJournal of Mathematical Biology, 2002
- Recovery of normal hemopoiesis in disseminated cancer therapy – a modelMathematical Biosciences, 2001
- Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK–PD modelComputers in Biology and Medicine, 2001
- Molecular biology of breast metastasis The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancerBreast Cancer Research, 2000
- Drug kinetics and drug resistance in optimal chemotherapyMathematical Biosciences, 1995